文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

住院期间抗栓治疗与华法林经皮冠状动脉介入治疗老年患者的结局：来自 WAR-STENT 登记研究的观察。

In-hospital antithrombotic therapy and outcomes of elderly patients on warfarin undergoing percutaneous coronary intervention: Insights from the WAR-STENT registry.

机构信息

Division of Cardiology, Maggiore Hospital, Bologna, Italy.

Cardiovascular Institute, University Hospital, Ferrara, Italy; Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy.

出版信息

Indian Heart J. 2022 May-Jun;74(3):256-257. doi: 10.1016/j.ihj.2022.04.011. Epub 2022 May 4.

DOI:10.1016/j.ihj.2022.04.011
PMID:35525302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9243611/
Abstract

In the patients on warfarin undergoing percutaneous coronary intervention included in the prospective, multicentre, observational WAR-STENT registry, age ≥75 years was associated with a significant increase in in-hospital major bleeding, length of hospitalization, and use of bare-metal stents, with no differences in the peri-procedural management and antithrombotic therapy.

摘要

在前瞻性、多中心、观察性 WAR-STENT 注册研究中纳入的正在接受经皮冠状动脉介入治疗的华法林患者中，年龄≥75 岁与住院期间大出血、住院时间延长和使用裸金属支架显著增加相关，而在围手术期管理和抗血栓治疗方面没有差异。

相似文献

[1]
In-hospital antithrombotic therapy and outcomes of elderly patients on warfarin undergoing percutaneous coronary intervention: Insights from the WAR-STENT registry.

Indian Heart J. 2022

[2]
[Periprocedural management of anticoagulation therapy and in-hospital outcomes in patients with warfarin indication undergoing percutaneous coronary intervention. Data from the WAR-STENT registry].

G Ital Cardiol (Rome). 2021-1

[3]
Twelve-month outcome of patients with an established indication for oral anticoagulation undergoing coronary artery stenting and stratified by the baseline risk of bleeding: Insights from the Warfarin and Coronary Stenting (War-Stent) Registry.

Cardiovasc Revasc Med. 2017-9

[4]
In-hospital management and outcome of patients on warfarin undergoing coronary stent implantation: results of the multicenter, prospective WARfarin and coronary STENTing (WAR-STENT) registry.

J Invasive Cardiol. 2013-4

[5]
Time-trends and treatment gaps in the antithrombotic management of patients with atrial fibrillation after percutaneous coronary intervention: Insights from the CHUM AF-STENT Registry.

Clin Cardiol. 2019-12-18

[6]
Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial.

JACC Cardiovasc Interv. 2018-3-14

[7]
Changes in antithrombotic therapy after a cerebrovascular or coronary ischemic event in the WARfarin and coronary STENTing (WAR-STENT) registry.

Panminerva Med. 2016-9

[8]
Triple antithrombotic therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.

Coron Artery Dis. 2015-8

[9]
In-Hospital Bleeding Outcomes of Myocardial Infarction in the Era of Warfarin and Direct Oral Anticoagulants for Atrial Fibrillation in the United States: A Report From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry.

J Am Heart Assoc. 2019-4-16

[10]
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update.

Circulation. 2018-7-31

引用本文的文献

[1]
Enhanced Reendothelialization and Thrombosis Prevention with a New Drug-Eluting Stent.

Cardiovasc Drugs Ther. 2024-6-4

本文引用的文献

[1]
Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare Beneficiaries.

JAMA Netw Open. 2021-12-1

[2]
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting.

Thromb Haemost. 2009-9-30

[3]
A prospective multicentre observational study on the management of patients on oral anticoagulation undergoing coronary artery stenting: rationale and design of the ongoing warfarin and coronary stenting (WAR-STENT) registry.

J Cardiovasc Med (Hagerstown). 2009-2

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索